Researchers emphasized the potential of Tezspire to offer a new treatment option that addresses the multiple inflammatory ...

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

"Chronic rhinosinusitis with nasal polyps negatively impact patients’ daily lives with obstructions leading to disturbances in smell, taste and sleep as well as pain and fatigue. The impressive data ...

Amgen (NASDAQ:AMGN) and AstraZeneca (NASDAQ:AZN) announced Friday that their FDA-approved asthma therapy Tezspire reached ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...

Chronic rhinosinusitis with nasal polyps can lead to obstructions in the nasal passage, resulting in disturbances in smell, ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...

A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...

showed efficacy in a phase 3 trial in patients with chronic rhinosinusitis with nasal polyps (CRwNP). The WAYPOINT trial ...

are a natural remedy to clear phlegm from your nasal passages. The saltwater solution draws out excess mucus and allergens that can cause nasal congestion, irritation, and inflammation.

Masala chai, the beloved Indian spiced tea, offers more than just warmth and flavor. Its blend of spices, including ginger, ...